These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6876570)

  • 21. The effect of hematocrit on peritoneal transport.
    Korbet SM; Vonesh EF; Firanek CA
    Am J Kidney Dis; 1991 Nov; 18(5):573-8. PubMed ID: 1951337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red cell survival and red cell enzymes in patients on continuous peritoneal dialysis (CAPD).
    Hefti JE; Blumberg A; Marti HR
    Clin Nephrol; 1983 May; 19(5):232-5. PubMed ID: 6851263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infrequent dosing of subcutaneous erythropoietin for the treatment of anemia in patients on CAPD.
    Bunke M; Bartlett DK; Brier ME; Golper TA
    Adv Perit Dial; 1993; 9():331-5. PubMed ID: 8105957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematocrit values in the CAPD/CCPD population: a report of the National CAPD Registry.
    Linblad AS; Nolph KD
    Perit Dial Int; 1990; 10(4):275-8. PubMed ID: 2096927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The red blood cell deformability in patients suffering from end stage renal failure on hemodialysis or continuous ambulatory peritoneal dialysis.
    Sotirakopoulos N; Tsitsios T; Stambolidou M; Athanasiou G; Peiou M; Kokkinou V; Mavromatidis K
    Ren Fail; 2004 Mar; 26(2):179-83. PubMed ID: 15287203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weekly subcutaneous recombinant human erythropoietin corrects anemia of progressive renal failure.
    Zappacosta AR; Perras ST; Bell A
    Am J Med; 1991 Sep; 91(3):229-32. PubMed ID: 1892142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experience with subcutaneous erythropoietin in CAPD patients.
    Bailie GR; Plitnick R; Eisele G; Clement C; Rasmussen R
    Adv Perit Dial; 1991; 7():292-5. PubMed ID: 1680449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematocrit above 30% in continuous ambulatory peritoneal dialysis patients treated with erythropoietin is harmful.
    Junor BJ
    Perit Dial Int; 1993; 13 Suppl 2():S535-7. PubMed ID: 8399658
    [No Abstract]   [Full Text] [Related]  

  • 30. How does rHuEPO effect D/P creatinine ratios?
    Richmond D; Broyan P; Shea S; Reft C; Poseno M; Gimenez LF
    Adv Perit Dial; 1992; 8():457-9. PubMed ID: 1361847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous ambulatory and continuous cycling peritoneal dialysis in children. A report of the Southwest Pediatric Nephrology Study Group.
    Kidney Int; 1985 Mar; 27(3):558-64. PubMed ID: 3999544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of l-carnitine supplementation on hematocrit and hemoglobin levels in patients with end stage renal failure on CAPD.
    Sotirakopoulos N; Athanasiou G; Tsitsios T; Mavromatidis K
    Ren Fail; 2002 Jul; 24(4):505-10. PubMed ID: 12212830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What happens after conversion of treatment to continuous ambulatory peritoneal dialysis from hemodialysis?
    Sezer S; Ozdemir N; Arat Z; Güz G; Sengül S; Akman B; Haberal A; Turan M; Haberal M
    Adv Perit Dial; 2000; 16():177-81. PubMed ID: 11045288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Workgroup.
    Frankenfield DL; Prowant BF; Flanigan MJ; Frederick PR; Bailie GR; Helgerson SD; Rocco MV
    Kidney Int; 1999 May; 55(5):1998-2010. PubMed ID: 10231465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.
    Madden MA; Zimmerman SW; Simpson DP
    Clin Nephrol; 1981 Dec; 16(6):293-9. PubMed ID: 6797767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic ambulatory peritoneal dialysis].
    Glasson P; Leski M; Favre H
    Schweiz Med Wochenschr; 1981 Aug; 111(34):1232-8. PubMed ID: 7025196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.